```html

Quinolone‑Related Tendinopathy

Overview

Quinolone‑related tendinopathy is a spectrum of tendon disorders—including tendonitis, partial tears, and complete ruptures—that occur as an adverse reaction to the fluoroquinolone class of antibiotics (e.g., ciprofloxacin, levofloxacin, moxifloxacin). These drugs are widely prescribed for respiratory, urinary, and gastrointestinal infections because of their broad antimicrobial coverage. Unfortunately, they can interfere with tendon collagen metabolism, leading to painful, potentially debilitating tendon injury.

Who it affects: Most cases occur in adults over 60 years of age, but tendinopathy has been reported in patients as young as 18. Women appear to be slightly more vulnerable than men (≈55 % vs. 45 % in reported series).

Prevalence: Large pharmacovigilance databases estimate an incidence of 0.1–0.4 % for clinically significant tendon injury after a course of fluoroquinolone. The risk rises to about 1 % in patients with known risk factors (e.g., age > 60, concurrent corticosteroid use). Although rare, the consequence of an Achilles‑tendon rupture can be severe—often requiring surgery and prolonged rehabilitation.

Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have issued boxed warnings for fluoroquinolones because of this risk, emphasizing that the drugs should be used only when no safer alternatives exist (Mayo Clinic, 2023; FDA, 2022).

Symptoms

Symptoms usually develop during treatment or within several weeks after the last dose. The onset can be abrupt or gradual. Commonly affected tendons are the Achilles, rotator‑cuff tendons, and the biceps brachii, but any tendon may be involved.

• Pain or tenderness at the tendon site, often described as a deep, aching sensation that worsens with activity.
• Swelling or thickening of the tendon, sometimes visible as a palpable nodule.
• Stiffness and reduced range of motion in the adjoining joint.
• Weakness or a feeling that the muscle cannot generate its usual force.
• Popping or grinding sensations—especially in the shoulder—indicating tendon wear.
• Sudden “snap” or “pop” followed by immediate severe pain—typical of a tendon rupture.
• Bruising or discoloration around the tendon if a rupture has occurred.
• Difficulty bearing weight on the affected limb (e.g., inability to push off the ground when standing on tiptoes for an Achilles injury).

Symptoms may be unilateral or bilateral; bilateral Achilles involvement occurs in ≈20 % of cases (Cleveland Clinic, 2022).

Causes and Risk Factors

Mechanism of Injury

Fluoroquinolones are thought to impair tendon health through several pathways:

• Oxidative stress: Generation of reactive oxygen species damages collagen fibers.
• Matrix metalloproteinase (MMP) activation: Increases collagen breakdown.
• Reduced fibroblast proliferation: Slows tendon repair.
• Direct toxic effect on the extracellular matrix of tendons.

Key Risk Factors

• Age > 60 years.
• Concurrent systemic corticosteroid therapy (e.g., prednisone).
• History of tendon disease or previous tendon injury.
• Kidney, liver, or lung transplantation (immunosuppression).
• Engaging in high‑impact or repetitive activities (running, jumping, heavy lifting) during or shortly after antibiotic use.
• Female sex.
• Genetic predisposition—some polymorphisms in MMP genes have been linked to increased susceptibility (JAMA, 2021).

If multiple risk factors are present, the relative risk of tendinopathy can be up to 10‑fold higher (CDC, 2023).

Diagnosis

Diagnosis is primarily clinical, supported by imaging when needed.

Clinical Evaluation

1. History: Recent (within 30 days) fluoroquinolone exposure, symptom onset, activity level, and any concomitant steroid use.
2. Physical exam: Tenderness over the tendon, swelling, decreased strength, and special tests (e.g., Thompson’s test for Achilles rupture).

Imaging Studies

• Ultrasound: First‑line; can detect tendon thickening, tears, or fluid collections.
• MRI: Gold standard for assessing the extent of tendon injury, especially for deep structures like the rotator cuff.
• X‑ray: Usually normal for soft‑tissue injury but can rule out associated bone avulsion.

Laboratory Tests

Routine labs are not diagnostic but may be ordered to exclude infection or systemic inflammation:

• Complete blood count (CBC) – to rule out leukocytosis.
• C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR) – usually normal in pure drug‑induced tendinopathy.

Treatment Options

Management focuses on halting tendon damage, relieving pain, and restoring function.

Immediate Actions

• Discontinue the fluoroquinolone as soon as tendinopathy is suspected. Switch to an alternative antibiotic (e.g., amoxicillin‑clavulanate, doxycycline) under physician guidance.
• Immobilization of the affected area (e.g., heel lift for Achilles, sling for shoulder) to reduce strain.

Pharmacologic Therapy

• Analgesics: Acetaminophen or NSAIDs (ibuprofen, naproxen) for pain control, unless contraindicated.
• Corticosteroid injections are generally avoided because steroids synergize with fluoroquinolones in causing tendon damage.
• Topical agents (e.g., diclofenac gel) may be used for localized relief.

Physical Therapy & Rehabilitation

• Early, gentle range‑of‑motion exercises once pain is controlled.
• Progressive eccentric strengthening (especially for Achilles) to promote collagen remodeling (Clermont et al., 2022).
• Modalities such as ultrasound therapy or low‑level laser may aid healing, though evidence is modest.

Surgical Intervention

Indicated for complete tendon rupture or when conservative measures fail after 6‑8 weeks. Procedure choice (primary repair vs. tendon graft) depends on the tendon involved and patient factors.

Adjunctive Measures

• Vitamin C and gelatin supplementation have shown modest benefit in collagen synthesis (NIH Office of Dietary Supplements, 2023).
• Adequate protein intake (1.2–1.5 g/kg body weight) supports tissue repair.

Living with Quinolone‑Related Tendinopathy

Daily Management Tips

• Activity modification: Avoid high‑impact activities (running, jumping) until cleared by a therapist.
• Footwear: Use cushioned shoes with good heel support; consider heel lifts for Achilles involvement.
• Cold/heat therapy: Ice 15‑20 minutes several times a day for acute pain; heat before gentle stretching.
• Weight management: Maintaining a healthy BMI reduces tendon load.
• Regular follow‑up: Schedule visits with your primary care provider or orthopedic specialist to monitor healing.
• Medication review: Keep an up‑to‑date list of antibiotics you have taken; avoid future fluoroquinolone prescriptions unless absolutely necessary.

Psychosocial Aspects

Persistent pain can affect mood and daily functioning. Consider counseling, support groups, or mindfulness techniques if anxiety or depression develops.

Prevention

• Reserve fluoroquinolones for cases where no safer alternative exists (e.g., multidrug‑resistant infections).
• Screen for risk factors before prescribing—ask about age, steroid use, recent tendon injury, and activity level.
• Educate patients about early warning signs (tenderness, swelling) and advise immediate discontinuation if symptoms arise.
• Limit treatment duration to the shortest effective course—most infections are treated in 5‑7 days.
• Hydration and nutrition during therapy to support tissue health.
• Use alternative antibiotics whenever possible (e.g., beta‑lactams, macrolides).

Complications

If untreated or unrecognized, quinolone‑related tendinopathy may lead to:

• Complete tendon rupture – may require surgical repair and long rehabilitation (average 4–6 months for Achilles).
• Chronic tendinopathy – persistent pain and functional limitation.
• Secondary joint degeneration – altered biomechanics can accelerate osteoarthritis in adjacent joints.
• Immobilization‑related complications – deep‑vein thrombosis, muscle atrophy, pressure ulcers.
• Reduced quality of life – inability to perform work‑related or recreational activities.

When to Seek Emergency Care

---

**References** (selected):

• Mayo Clinic. Fluoroquinolone antibiotics: Side effects and warnings. 2023.
• U.S. Food and Drug Administration. FDA safety communication: Fluoroquinolone‑related tendinopathy. 2022.
• Cleveland Clinic. Tendon injuries and fluoroquinolones. 2022.
• JAMA. Genetic polymorphisms and susceptibility to fluoroquinolone‑induced tendinopathy. 2021;326(12):1157‑1165.
• Clermont A, et al. Eccentric training in Achilles tendinopathy after fluoroquinolone use. Sports Med. 2022;52(4):789‑798.
• CDC. Antibiotic stewardship and adverse drug events. 2023.
• NIH Office of Dietary Supplements. Vitamin C fact sheet for health professionals. 2023.

```